What is the main business of Oncotarget Wojciech Jurczak?

The main business activity of Oncotarget Wojciech Jurczak focuses on other research and experimental development on natural sciences and engineering.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on June 8, 2022.

Where is the headquarters located?

The headquarters is located at: ul. Jana I Józefa Kotlarczyków 4, 30-225 Kraków.

What is the share capital?

The share capital of the company is PLN 50,000 (approx. $13,506).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What was the revenue?

In 2025, the company generated total revenue of $192,291, representing an increase of 24.7% compared to 2024.

Is the company profitable?

Yes, in 2025 the company was profitable, achieving a net profit of $112,313, meaning the company increased its profit by 27.1%.

Which cost dominates operating expenses?

The largest operating cost category falls under other operating costs. This category amounted to $45,352 in 2025, representing 70% of all operating expenses.

Oncotarget Wojciech JurczakS.K.A.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2022-06-08

Share capital

50 000,00 PLN

Activity description

Oncotarget Wojciech Jurczak is involved in the organization and conduct of clinical research focused on patients diagnosed with lymphoma, chronic lymphoid leukemia, and multiple myeloma. The company has completed over 200 studies that contributed to the approval of novel molecularly targeted agents, targeted chemotherapy compounds, and immunotherapies. Additionally, they advocate for Poland as a prime location for conducting clinical trials.

Registered address

ul. Jana I Józefa Kotlarczyków 4, 30-225 Kraków, Poland

Website

oncotarget.pl

Social media

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 192.29kMedianUSD 72.17kAverageUSD 3.11m

Net profit

This companyUSD 112.31kMedianUSD 69.14AverageUSD 80.67k

Operating costs

This companyUSD 65.20kMedianUSD 75.48kAverageUSD 2.93m

Assets

This companyUSD 217.16kMedianUSD 121.09kAverageUSD 3.89m

Industry

Bank accounts

Registered as a VAT taxpayer on 2022-08-01. Active

mBank
33 1140 1081 0000 4482 2400 1004
mBank
17 1140 1081 0000 4482 2400 1001
mBank
87 1140 1081 0000 4482 2400 1002

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

General partners

Wojciech Jan Jurczak (60)

Manner of representation

The company is represented by the general partner.

Beneficial owners

Person	Rights

Competitors

Name	Revenue	Website
CTI Clinical Trial And Consulting Services Polandsp. z o.o.	$527,145.56	ctifacts.com
Digital Pathology Team Witold Reznersp. k.	$383,078.99	digitalpathologyteam.com
Medicofarma BiotechS.A.	$314,882.33	medicofarmabiotech.pl
CCTSsp. z o.o.	$281,193.31	ccts.pl
Specjalistyczne Gabinetysp. z o.o.	$239,872.14	specjalistycznegabinety.pl
TCIsp. z o.o.	$218,471.87	tci.pl
Dicellasp. z o.o.	$206,073.49	dicella.com
Gcp-Service International Ltd. & Co. KgBranch (foreign co.)	$159,376.34	gcp-service.com
Pharmaxi Polandsp. z o.o.	$152,292.34	pharmaxi.com.ua
CBK Med Clinicsp. z o.o.	$91,889.00	cbkmedclinic.pl

FAQ

Last updated: 2026-04-09